Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get StartedHow you prepare
By Mayo Clinic staffFollow your doctor's instructions on what to do before your treatment.
- Stop or reduce blood thinning medications if your doctor says to. Examples include warfarin (Coumadin) and some over-the-counter pain relievers such as aspirin, ibuprofen or naproxen. Acetaminophen (Tylenol, others) is generally OK.
- Don't eat or drink anything after midnight the night before your treatment unless your doctor tells you otherwise.
- Take only the medications your doctor tells you to with a small sip of water on the morning of your procedure.
- Arrange a ride home ahead of time. You won't be able to drive right after the procedure.
Your doctor may also give you other steps to follow.
References
- Fitzpatrick JM, et al. Minimally invasive and endoscopic management of benign prostatic hyperplasia. In: Wein AJ, et al. Campbell-Walsh Urology. 9th ed. Philadelphia, Pa.: Saunders Elsevier; 2007. http://www.mdconsult.com/das/book/body/125743340-3/0/1445/91.html?tocnode=54305416&fromURL=91.html. Accessed March 12, 2009.
- AUA guideline on the management of benign prostatic hyperplasia: Diagnosis and treatment recommendations. Baltimore, Md.: American Urological Association. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/bph-management/chapt_1_appendix.pdf. Accessed March 12, 2009.
- d'Ancona FC. Nonablative minimally invasive thermal therapies in the treatment of symptomatic benign prostatic hyperplasia. Current Opinion in Urology. 2008;18:21.
- Gravas S et al. Transurethral microwave thermotherapy: From evidence-based medicine to clinical practice. Current Opinion in Urology. 2007;17:12.
- Hoffman RM et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. 2007:CD004135.
- Cunningham GR, et al. Surgical and other invasive therapies of benign prostatic hyperplasia. http://www.uptodate.com/home/index.html. Accessed March 12, 2009.